H. Lundbeck A/S (HLUBF)
HLUBF Stock Price Chart
Explore H. Lundbeck A/S interactive price chart. Choose custom timeframes to analyze HLUBF price movements and trends.
HLUBF Company Profile
Discover essential business fundamentals and corporate details for H. Lundbeck A/S (HLUBF) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
13 Jul 2022
Employees
5.71K
Website
https://www.lundbeck.comCEO
Charl van Zyl
Description
H. Lundbeck A/S, a biopharmaceutical company, engages in the research, development, production, and sale of pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, North America, and internationally. The company's principal products include Abilify Maintena for schizophrenia; Brintellix/Trintellix to treat depression; Northera for the treatment of symptomatic neurogenic orthostatic hypotension; Vyepti for migraine prevention; and Rexulti/Rxulti to treat depression/schizophrenia. It also provides Azilect for treating Parkinson's disease; Cipralex/Lexapro for depression; Ebixa to treat Alzheimer's disease; Onfi for Lennox-Gastaut syndrome; Sabril for treating epilepsy; and Xenazine for chorea associated with Huntington's disease, as well as other products. The company sells its products primarily to distributors of pharmaceuticals, pharmacies, and hospitals. It has a partnership agreement with Verantos to focus on a study to enable real-world evidence in support of migraine therapy; and collaboration with Rgenta Therapeutics, Inc. The company was founded in 1915 and is headquartered in Valby, Denmark.
HLUBF Financial Timeline
Browse a chronological timeline of H. Lundbeck A/S corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 12 Nov 2025
Revenue estimate is $6.09B.
Earnings released on 14 Aug 2025
EPS came in at $0.15 , while revenue for the quarter reached $950.25M , missing expectations by -84.34%.
Earnings released on 14 May 2025
EPS came in at $0.17 , while revenue for the quarter reached $917.67M , missing expectations by -84.63%.
Dividend declared on 27 Mar 2025
A dividend of $0.14 per share was announced, adjusted to $0.14. The dividend was paid on 31 Mar 2025.
Earnings released on 5 Feb 2025
EPS came in at $0.08 , while revenue for the quarter reached $766.87M , missing expectations by -86.82%.
Earnings released on 13 Nov 2024
EPS came in at $0.11 , while revenue for the quarter reached $3.05B .
Earnings released on 20 Aug 2024
EPS came in at $0.11 , while revenue for the quarter reached $785.18M .
Earnings released on 15 May 2024
EPS came in at $0.15 , while revenue for the quarter reached $759.36M .
Dividend declared on 21 Mar 2024
A dividend of $0.10 per share was announced, adjusted to $0.10. The dividend was paid on 25 Mar 2024.
Earnings released on 20 Mar 2024
EPS came in at $0.02 , while revenue for the quarter reached $734.60M .
Earnings released on 31 Jan 2024
EPS came in at $0.10 , while revenue for the quarter reached $698.73M .
Earnings released on 30 Jun 2023
EPS came in at $0.09 , while revenue for the quarter reached $721.40M .
Earnings released on 31 Mar 2023
EPS came in at $0.13 , while revenue for the quarter reached $735.36M .
Dividend declared on 22 Mar 2023
A dividend of $0.08 per share was announced, adjusted to $0.08. The dividend was paid on 24 Mar 2023.
Earnings released on 31 Dec 2022
EPS came in at $0.05 , while revenue for the quarter reached $675.97M .
Earnings released on 30 Sept 2022
EPS came in at $0.09 , while revenue for the quarter reached $618.47M .
Earnings released on 30 Jun 2022
EPS came in at $0.07 , while revenue for the quarter reached $628.34M .
Earnings released on 31 Mar 2022
EPS came in at $0.06 , while revenue for the quarter reached $650.22M .
Earnings released on 31 Dec 2021
EPS came in at -$0.00 , while revenue for the quarter reached $617.72M .
Earnings released on 30 Sept 2021
EPS came in at $0.05 , while revenue for the quarter reached $626.11M .
Earnings released on 30 Jun 2021
EPS came in at $0.06 , while revenue for the quarter reached $631.26M .
Earnings released on 31 Mar 2021
EPS came in at $0.49 , while revenue for the quarter reached $675.08M .
Earnings released on 31 Dec 2020
EPS came in at $0.31 , while revenue for the quarter reached $701.13M .
Earnings released on 30 Sept 2020
EPS came in at $0.33 , while revenue for the quarter reached $703.35M .
HLUBF Stock Performance
Access detailed HLUBF performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.